146 related articles for article (PubMed ID: 11036378)
1. [Quality registry for better treatment of rectal cancer established. Economical support is required to use the benefits of the information].
Bohe M; Cedermark B; Damber L; Lewin F; Lindmark G; Nordgren S; Påhlman L; Sjödahl R
Lakartidningen; 2000 Aug; 97(34):3587-8, 3591. PubMed ID: 11036378
[TBL] [Abstract][Full Text] [Related]
2. The influence on treatment outcome of structuring rectal cancer care.
Påhlman L; Gunnarsson U; Karlbom U
Eur J Surg Oncol; 2005 Aug; 31(6):645-9. PubMed ID: 15893909
[TBL] [Abstract][Full Text] [Related]
3. Nationwide quality assurance of rectal cancer treatment.
Wibe A; Carlsen E; Dahl O; Tveit KM; Weedon-Fekjaer H; Hestvik UE; Wiig JN;
Colorectal Dis; 2006 Mar; 8(3):224-9. PubMed ID: 16466564
[TBL] [Abstract][Full Text] [Related]
4. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy.
Holm T; Johansson H; Cedermark B; Ekelund G; Rutqvist LE
Br J Surg; 1997 May; 84(5):657-63. PubMed ID: 9171755
[TBL] [Abstract][Full Text] [Related]
5. [Improved therapeutic results in rectal cancer. Preoperative radiotherapy and continuing education of the surgeons is efficient].
Holm T; Cedermark B; Johansson H; Singnomklao T; Rutqvist LE
Lakartidningen; 2000 Aug; 97(34):3582-6. PubMed ID: 11036377
[TBL] [Abstract][Full Text] [Related]
6. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.
Folkesson J; Birgisson H; Pahlman L; Cedermark B; Glimelius B; Gunnarsson U
J Clin Oncol; 2005 Aug; 23(24):5644-50. PubMed ID: 16110023
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
8. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.
Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the treatment of rectal cancer: a population based study.
Martling A; Granath F; Cedermark B; Johansson R; Holm T
Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417
[TBL] [Abstract][Full Text] [Related]
10. [Surgery and radiotherapy best in the treatment of rectal cancer. Correct use of patient registries can further increase the quality].
Påhlman L
Lakartidningen; 2000 Aug; 97(34):3564-6. PubMed ID: 11036375
[No Abstract] [Full Text] [Related]
11. Registration and validity of surgical complications in colorectal cancer surgery.
Gunnarsson U; Seligsohn E; Jestin P; Påhlman L
Br J Surg; 2003 Apr; 90(4):454-9. PubMed ID: 12673748
[TBL] [Abstract][Full Text] [Related]
12. Structuring rectal cancer treatment in Scandinavia.
Påhlman L; Laurberg S; Søreide O
Surg Oncol Clin N Am; 2001 Oct; 10(4):855-62, x. PubMed ID: 11641095
[TBL] [Abstract][Full Text] [Related]
13. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial.
Birgisson H; Påhlman L; Gunnarsson U; Glimelius B;
J Clin Oncol; 2005 Dec; 23(34):8697-705. PubMed ID: 16314629
[TBL] [Abstract][Full Text] [Related]
15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
17. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
[TBL] [Abstract][Full Text] [Related]
19. Impact of radiotherapy on local recurrence of rectal cancer in Norway.
Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B;
Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant therapy of rectal cancer].
Bouaouina N; Boussen H
Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
